BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Press Releases

  Quantum BioPharma Corporate Update

  April 21, 2025

   · 

  4 min read
• Press Releases

  Johnson & Johnson unveils highly anticipated and potential practice-changing data in bladder cancer treatment at AUA

  April 21, 2025

   · 

  10 min read
• Press Releases

  Coya Therapeutics Announces Publication of GLP-1/LD IL-2 Combination Biologic (COYA 303) Demonstrating Synergistic Enhancement of Regulatory T Cell Function and Protection Against Treg Apoptosis (Cell Death)

  April 21, 2025

   · 

  8 min read
• 

  Layoffs

  Tempest Cuts 80% of Staff While Considering Strategic Alternatives

  California-based Tempest Therapeutics is laying off 21 of its 26 full-time employees. The cuts come while the biotech is exploring strategic alternatives, including a merger or acquisition, as it tries to move its investigational PPARα antagonist into late-stage development.

  April 21, 2025

   · 

  1 min read

   · 

  Angela Gabriel
• Press Releases

  Perfuse Therapeutics Announces Oral Presentation on PER-001 Intravitreal Implant for Glaucoma at the Association for Research in Vision and Ophthalmology (ARVO) Meeting

  April 21, 2025

   · 

  3 min read
• Press Releases

  Ferring Unveils New Data with ADSTILADRIN® (nadofaragene firadenovec-vncg) at 112th Annual Meeting of the Japanese Urological Association

  April 21, 2025

   · 

  11 min read
• Press Releases

  Ferring Announces Initial Data from Phase 3 Trial in Japanese Patients Demonstrating 75% Complete Response Rate at 3 Months with (nadofaragene firadenovec) in BCG-unresponsive NMIBC Patients1

  April 21, 2025

   · 

  9 min read
• 

  FDA

  Banning Industry From FDA Adcomms Won’t ‘Move the Needle Much’ in Makary, RFK’s Fight Against COIs

  FDA Commissioner Marty Makary last week announced a directive that would limit industry participation in the agency’s advisory committees. But not only do company reps serve only as non-voting members, a 1997 law actually requires industry involvement.

  April 21, 2025

   · 

  5 min read

   · 

  Heather McKenzie
• Press Releases

  NeuroNOS Granted FDA Orphan Drug Designation for Phelan-McDermid Syndrome, a Neurodevelopmental Disorder Linked to Autism

  April 21, 2025

   · 

  7 min read
• Press Releases

  Exagen Inc. to Announce First Quarter 2025 Financial Results on May 5, 2025

  April 21, 2025

   · 

  1 min read